T1	PROC 44 66	Estudio de la eficacia
T2	CHEM 80 91	tobramicina
#1	AnnotatorNotes T2	C0040341; tobramycin; Antibiotic · Organic Chemical
T3	DISO 205 243	colonizado por bacterias Gram negativo
T4	PROC 136 156	ventilación mecánica
#2	AnnotatorNotes T4	C0199470; Mechanical ventilation; Therapeutic or Preventive Procedure
T5	PROC 182 202	ventilación mecánica
#3	AnnotatorNotes T5	C0199470; Mechanical ventilation; Therapeutic or Preventive Procedure
T6	DISO 417 457	colonizados por bacterias Gram negativas
T7	PROC 265 309	Ensayo clínico fase III aleatorizado y ciego
T8	DISO 859 871	Colonización
#4	AnnotatorNotes T8	C4289767; Colonization; Finding
T9	CHEM 326 337	tobramicina
#5	AnnotatorNotes T9	C0040341; tobramycin; Antibiotic · Organic Chemical
T10	PROC 361 368	placebo
#6	AnnotatorNotes T10	C0032042; Placebos; Therapeutic or Preventive Procedure
T11	PROC 394 414	ventilación mecánica
#7	AnnotatorNotes T11	C0199470; Mechanical ventilation; Therapeutic or Preventive Procedure
T12	DISO 1639 1678	Colonización respiratoria por bacterias
T13	PROC 463 484	comprobar su eficacia
T14	PROC 515 535	ventilación mecánica
#8	AnnotatorNotes T14	C0199470; Mechanical ventilation; Therapeutic or Preventive Procedure
T15	PROC 589 609	ventilación mecánica
#9	AnnotatorNotes T15	C0199470; Mechanical ventilation; Therapeutic or Preventive Procedure
T16	PROC 666 683	ingresados en UCI
#10	AnnotatorNotes T16	C5419131; Intensive Care Unit Stay; Health Care Activity
T17	PROC 697 717	ventilación mecánica
#11	AnnotatorNotes T17	C0199470; Mechanical ventilation; Therapeutic or Preventive Procedure
T18	PROC 776 789	traqueostomía
#12	AnnotatorNotes T18	C0040590; Tracheostomy procedure; Therapeutic or Preventive Procedure
T19	ANAT 890 899	vía aérea
#13	AnnotatorNotes T19	C0458827; Airway structure; Body Part, Organ, or Organ Component
T20	CHEM 941 952	tobramicina
#14	AnnotatorNotes T20	C0040341; tobramycin; Antibiotic · Organic Chemical
T21	DISO 1118 1128	Broncorrea
#15	AnnotatorNotes T21	C0235568; Bronchorrhea; Sign or Symptom
T22	DISO 1275 1282	Alergia
#16	AnnotatorNotes T22	C1527304; Allergic Reaction; Pathologic Function
T23	CHEM 1285 1300	aminoglucósidos
#17	AnnotatorNotes T23	C0002556; Aminoglycosides; Organic Chemical · Pharmacologic Substance
T24	DISO 1347 1366	Insuficiencia renal
#18	AnnotatorNotes T24	C0035078; Kidney Failure; Disease or Syndrome | C1565489; Renal Insufficiency; Disease or Syndrome
T25	CHEM 1381 1391	creatinina
#19	AnnotatorNotes T25	C0010294; creatinine; Biologically Active Substance · Organic Chemical
T26	PROC 1412 1434	depuración extrarrenal
T27	DISO 1506 1528	infección respiratoria
#20	AnnotatorNotes T27	C0035243; Respiratory Tract Infections; Disease or Syndrome
T28	PROC 1543 1563	ventilación mecánica
#21	AnnotatorNotes T28	C0199470; Mechanical ventilation; Therapeutic or Preventive Procedure
T29	DISO 1565 1573	neumonía
#22	AnnotatorNotes T29	C0032285; Pneumonia; Disease or Syndrome
T30	DISO 1576 1593	traqueobronquitis
#23	AnnotatorNotes T30	C0040586; Tracheobronchitis; Disease or Syndrome
T31	PROC 1319 1343	consentimiento informado
#24	AnnotatorNotes T31	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T32	CHEM 1696 1707	tobramicina
#25	AnnotatorNotes T32	C0040341; tobramycin; Antibiotic · Organic Chemical
T33	PROC 1772 1786	ensayo clínico
#26	AnnotatorNotes T33	C0008976; Clinical Trials; Research Activity
T34	DISO 1813 1828	Bronquiectasias
#27	AnnotatorNotes T34	C0006267; Bronchiectasis; Disease or Syndrome
T35	DISO 1831 1848	fibrosis quística
#28	AnnotatorNotes T35	C0010674; Cystic Fibrosis; Disease or Syndrome
T36	CHEM 1892 1902	furosemida
#29	AnnotatorNotes T36	C0016860; furosemide; Organic Chemical · Pharmacologic Substance
T37	CHEM 1904 1908	urea
#30	AnnotatorNotes T37	C0041942; urea; Biologically Active Substance · Organic Chemical · Pharmacologic Substance
T38	CHEM 1911 1918	manitol
#31	AnnotatorNotes T38	C0024730; mannitol; Organic Chemical · Pharmacologic Substance
T39	ANAT 1039 1061	muestras respiratorias
T40	DISO 1143 1152	purulenta
#32	AnnotatorNotes T40	C3203360; Suppuration; Pathologic Function
T41	ANAT 1361 1366	renal
#33	AnnotatorNotes T41	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T42	PROC 1368 1391	aclaramiento creatinina
T43	PROC 1879 1887	tratados
#34	AnnotatorNotes T43	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T44	Date 12 16	2015
T45	Route 92 100	inhalada
#35	AnnotatorNotes T45	C0205535; Inhalation Route of Drug Administration; Functional Concept
T46	LIVB 160 169	pacientes
#36	AnnotatorNotes T46	C0030705; Patients; Patient or Disabled Group
T47	LIVB 220 243	bacterias Gram negativo
#37	AnnotatorNotes T47	C0018150; Gram Negative Bacteria; Bacteria
T49	Route 338 346	inhalada
#38	AnnotatorNotes T49	C0205535; Inhalation Route of Drug Administration; Functional Concept
T50	LIVB 372 381	pacientes
#39	AnnotatorNotes T50	C0030705; Patients; Patient or Disabled Group
T51	LIVB 433 457	bacterias Gram negativas
#40	AnnotatorNotes T51	C0018150; Gram Negative Bacteria; Bacteria
T53	LIVB 558 576	Pacientes críticos
#41	AnnotatorNotes T53	C0030705; Patients; Patient or Disabled Group + C0815272; critical population; Population Group
T54	LIVB 636 645	Pacientes
#42	AnnotatorNotes T54	C0030705; Patients; Patient or Disabled Group
T55	Age 646 664	mayores de 18 años
T56	DEVI 756 773	tubo endotraqueal
#43	AnnotatorNotes T56	C0336630; Endotracheal tube; Medical Device
T57	Duration 799 814	al menos 7 días
T58	LIVB 904 928	bacterias Gram negativas
#44	AnnotatorNotes T58	C0018150; Gram Negative Bacteria; Bacteria
T60	LIVB 1008 1022	microorganismo
#45	AnnotatorNotes T60	C0445623; Microorganism; Organism
T63	Duration 1100 1113	mínimo de 72h
T64	PHYS 1213 1233	proceso respiratorio
#46	AnnotatorNotes T64	C0035203; Respiration; Physiologic Function
T65	LIVB 1238 1246	paciente
#47	AnnotatorNotes T65	C0030705; Patients; Patient or Disabled Group
T68	LIVB 1437 1482	Mujeres embarazadas o en periodo de lactancia
#48	AnnotatorNotes T68	C0033011; Pregnant Women; Population Group | C4316174; Patients who are breastfeeding; Patient or Disabled Group
T69	Spec_cue 1492 1505	sugestivos de
T70	LIVB 1669 1678	bacterias
#49	AnnotatorNotes T70	C0004611; Bacteria; Bacterium
T71	Duration 1790 1809	los 30 días previos
T72	LIVB 1852 1861	Pacientes
#50	AnnotatorNotes T72	C0030705; Patients; Patient or Disabled Group
T75	ANAT 1516 1528	respiratoria
#51	AnnotatorNotes T75	C0035237; Respiratory System; Body System | C1269561; Entire respiratory system; Body System
T76	ANAT 1652 1664	respiratoria
#52	AnnotatorNotes T76	C0035237; Respiratory System; Body System | C1269561; Entire respiratory system; Body System
T48	DEVI 734 754	vía aérea artificial
#53	AnnotatorNotes T48	C3873832; Artificial airway device; Medical Device
T52	LIVB 1170 1188	médico asistencial
#54	AnnotatorNotes T52	C1320929; Attending physician; Professional or Occupational Group
T59	Neg_cue 1304 1318	Denegación del
T61	PHYS 1473 1482	lactancia
#55	AnnotatorNotes T61	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T62	PHYS 1445 1456	embarazadas
#56	AnnotatorNotes T62	C0032961; Pregnancy; Organism Function
A1	Assertion T27 Speculated
A2	Assertion T31 Negated
A3	Status T22 History_of
#57	AnnotatorNotes T1	C1707887; Efficacy Study; Research Activity
#58	AnnotatorNotes T13	C1707887; Efficacy Study; Research Activity
#59	AnnotatorNotes T7	C0282461; Phase 3 Clinical Trials; Research Activity + C0034656; Randomization; Research Activity + C0150108; Blinded; Research Activity
#60	AnnotatorNotes T39	C0444279; Respiratory sample; Body Substance
#61	AnnotatorNotes T42	C0373595; Creatinine clearance measurement; Laboratory Procedure
T66	PROC 230 234	Gram
#62	AnnotatorNotes T66	C0200966; Bacterial stain, routine; Laboratory Procedure
T67	PROC 443 447	Gram
#63	AnnotatorNotes T67	C0200966; Bacterial stain, routine; Laboratory Procedure
T73	PROC 914 918	Gram
#64	AnnotatorNotes T73	C0200966; Bacterial stain, routine; Laboratory Procedure
T74	Spec_cue 1189 1195	podría
T77	CONC 1196 1206	interferir
A4	Assertion T77 Speculated
#65	AnnotatorNotes T77	C0521102; Interferes with; Functional Concept
R1	Has_Route_or_Mode Arg1:T2 Arg2:T45	
R2	Experiences Arg1:T46 Arg2:T2	
R3	Experiences Arg1:T46 Arg2:T4	
R4	Experiences Arg1:T46 Arg2:T5	
R5	Experiences Arg1:T46 Arg2:T3	
R6	Causes Arg1:T47 Arg2:T3	
R7	Has_Route_or_Mode Arg1:T9 Arg2:T49	
R8	Experiences Arg1:T50 Arg2:T9	
R9	Experiences Arg1:T50 Arg2:T10	
R10	Experiences Arg1:T50 Arg2:T11	
R11	Experiences Arg1:T50 Arg2:T6	
R12	Causes Arg1:T51 Arg2:T6	
R16	Experiences Arg1:T50 Arg2:T14	
R18	Experiences Arg1:T53 Arg2:T15	
R19	Has_Age Arg1:T54 Arg2:T55	
R20	Experiences Arg1:T54 Arg2:T16	
R21	Overlap Arg1:T16 Arg2:T17	
R22	Experiences Arg1:T54 Arg2:T17	
R23	Experiences Arg1:T54 Arg2:T48	
R24	Overlap Arg1:T17 Arg2:T48	
R25	Overlap Arg1:T17 Arg2:T56	
R26	Overlap Arg1:T17 Arg2:T18	
R27	Experiences Arg1:T54 Arg2:T56	
R28	Experiences Arg1:T54 Arg2:T18	
R29	Has_Duration_or_Interval Arg1:T17 Arg2:T57	
R30	Has_Duration_or_Interval Arg1:T48 Arg2:T57	
R31	Has_Duration_or_Interval Arg1:T56 Arg2:T57	
R32	Has_Duration_or_Interval Arg1:T18 Arg2:T57	
R33	Location_of Arg1:T19 Arg2:T8	
R34	Causes Arg1:T58 Arg2:T8	
T78	Quantifier_or_Qualifier 872 883	persistente
#66	AnnotatorNotes T78	C0205322; Persistent; Temporal Concept
R35	Has_Quantifier_or_Qualifier Arg1:T8 Arg2:T78	
T79	Observation 929 952	sensibles a tobramicina
R36	Overlap Arg1:T79 Arg2:T20	
R37	Has_Quantifier_or_Qualifier Arg1:T58 Arg2:T79	
T80	Quantifier_or_Qualifier 966 977	persistente
#67	AnnotatorNotes T80	C0205322; Persistent; Temporal Concept
R38	Has_Quantifier_or_Qualifier Arg1:T60 Arg2:T80	
T81	Quantifier_or_Qualifier 1026 1038	al menos dos
R39	Has_Quantifier_or_Qualifier Arg1:T39 Arg2:T81	
R40	Has_Duration_or_Interval Arg1:T80 Arg2:T63	
R41	Experiences Arg1:T65 Arg2:T21	
R42	Experiences Arg1:T65 Arg2:T40	
R43	Experiences Arg1:T65 Arg2:T64	
R44	Speculation Arg1:T74 Arg2:T77	
T82	Quantifier_or_Qualifier 1129 1138	abundante
#68	AnnotatorNotes T82	C2346714; Abundance; Qualitative Concept
R47	Has_Quantifier_or_Qualifier Arg1:T21 Arg2:T82	
R48	Causes Arg1:T23 Arg2:T22	
R49	Negation Arg1:T59 Arg2:T31	
R50	Location_of Arg1:T41 Arg2:T24	
T83	Result_or_Value 1392 1402	<60 ml/min
R52	Has_Result_or_Value Arg1:T42 Arg2:T83	
#69	AnnotatorNotes T26	C0206074; Renal Replacement Therapy; Therapeutic or Preventive Procedure (?)
R53	Experiences Arg1:T68 Arg2:T62	
R54	Experiences Arg1:T68 Arg2:T61	
R55	Location_of Arg1:T75 Arg2:T27	
R56	Speculation Arg1:T69 Arg2:T27	
R57	Overlap Arg1:T27 Arg2:T28	
R58	Overlap Arg1:T28 Arg2:T29	
R59	Overlap Arg1:T28 Arg2:T30	
T84	CONC 1612 1621	inclusión
#70	AnnotatorNotes T84	C1512693; Inclusion; Qualitative Concept
R60	Overlap Arg1:T27 Arg2:T84	
R61	Overlap Arg1:T28 Arg2:T84	
R62	Overlap Arg1:T29 Arg2:T84	
R63	Overlap Arg1:T30 Arg2:T84	
R64	Location_of Arg1:T76 Arg2:T12	
R65	Causes Arg1:T70 Arg2:T12	
T85	Observation 1679 1707	resistentes a la tobramicina
R66	Has_Quantifier_or_Qualifier Arg1:T12 Arg2:T85	
T86	PROC 1711 1746	Limitación del esfuerzo terapéutico
T87	Observation 1750 1786	Participación en otro ensayo clínico
R67	Overlap Arg1:T87 Arg2:T71	
R68	Overlap Arg1:T33 Arg2:T71	
R69	Experiences Arg1:T72 Arg2:T43	
R70	Used_for Arg1:T36 Arg2:T43	
R71	Used_for Arg1:T37 Arg2:T43	
R72	Used_for Arg1:T38 Arg2:T43	
R73	Location_of Arg1:T39 Arg2:T60	
R13	Overlap Arg1:T21 Arg2:T40	
#71	AnnotatorNotes T86	C0871549; Withholding Treatment; Health Care Activity
A5	Experiencer T46 Patient
A6	Experiencer T50 Patient
A7	Experiencer T53 Patient
A8	Experiencer T54 Patient
A9	Experiencer T52 Other
A10	Experiencer T65 Patient
A11	Experiencer T68 Patient
A12	Experiencer T72 Patient
T88	Result_or_Value 919 928	negativas
R14	Has_Result_or_Value Arg1:T73 Arg2:T88	
T89	Result_or_Value 448 457	negativas
R15	Has_Result_or_Value Arg1:T67 Arg2:T89	
T90	Result_or_Value 235 243	negativo
R17	Has_Result_or_Value Arg1:T66 Arg2:T90	
